Literature DB >> 18799801

Systemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic rat.

David W Hein1, Jean Bendaly, Jason R Neale, Mark A Doll.   

Abstract

Rat lines congenic for the rat N-acetyltransferase 2 [(RAT)Nat2] gene were constructed and characterized. F344 (homozygous Nat2 rapid) males were mated to Wistar Kyoto (homozygous Nat2 slow) females to produce heterozygous F1. F1 females were then backcrossed to F344 males. Heterozygous acetylator female progeny from this and each successive backcross were identified by rat Nat2 genotyping and mated with F344 rapid acetylator males. After 10 generations of backcross mating, heterozygous acetylator brother/sister progeny were mated to produce the homozygous rapid and slow acetylator Nat2 congenic rat lines. p-Aminobenzoic acid (selective for rat NAT2) and 4-aminobiphenyl N-acetyltransferase activities were expressed in all tissues examined (liver, lung, esophagus, stomach, small intestine, colon, pancreas, kidney, skin, leukocytes, and urinary bladder in male and female rats and in breast of female and prostate of male rats). NAT2 expression in rat extrahepatic tissues was much higher than that in liver. In each tissue, activities were Nat2-genotype-dependent, with the highest levels in homozygous rapid acetylators, intermediate levels in heterozygous acetylators, and lowest in homozygous slow acetylators. Sulfamethazine (selective for rat NAT1) N-acetyltransferase activities were observed in all tissues examined in both male and female rats except for breast (females), bladder, and leukocytes. In each tissue, the activity was Nat2 genotype-independent, with similar levels in homozygous rapid, heterozygous, and homozygous slow acetylators. These congenic rat lines are useful for investigating the role of NAT2 genetic polymorphisms in susceptibility to cancers related to arylamine carcinogen exposures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799801      PMCID: PMC2596689          DOI: 10.1124/dmd.108.023960

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  49 in total

1.  Higher DNA adduct levels in urinary bladder and prostate of slow acetylator inbred rats administered 3,2'-dimethyl-4-aminobiphenyl.

Authors:  W Jiang; Y Feng; D W Hein
Journal:  Toxicol Appl Pharmacol       Date:  1999-05-01       Impact factor: 4.219

2.  Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.

Authors:  Jason M Walraven; Mark A Doll; David W Hein
Journal:  J Pharmacol Exp Ther       Date:  2006-07-07       Impact factor: 4.030

3.  Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1.

Authors:  David F Barker; Anwar Husain; Jason R Neale; Benjamin D Martini; Xiaoyan Zhang; Mark A Doll; J Christopher States; David W Hein
Journal:  Pharmacogenet Genomics       Date:  2006-07       Impact factor: 2.089

4.  Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.

Authors:  K S Sugamori; D Brenneman; S Wong; A Gaedigk; V Yu; H Abramovici; R Rozmahel; D M Grant
Journal:  Drug Metab Dispos       Date:  2007-04-02       Impact factor: 3.922

5.  N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice.

Authors:  Jennifer A Loehle; Valerie Cornish; Larissa Wakefield; Mark A Doll; Jason R Neale; Yu Zang; Edith Sim; David W Hein
Journal:  J Pharmacol Exp Ther       Date:  2006-07-20       Impact factor: 4.030

6.  Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues.

Authors:  Anwar Husain; Xiaoyan Zhang; Mark A Doll; J Christopher States; David F Barker; David W Hein
Journal:  Drug Metab Dispos       Date:  2007-02-07       Impact factor: 3.922

7.  Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements.

Authors:  Anwar Husain; Xiaoyan Zhang; Mark A Doll; J Christopher States; David F Barker; David W Hein
Journal:  Drug Metab Dispos       Date:  2007-06-25       Impact factor: 3.922

8.  Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and Functional characterization of a novel rNat3*2 genetic variant.

Authors:  Jason M Walraven; David F Barker; Mark A Doll; David W Hein
Journal:  Toxicol Sci       Date:  2007-06-12       Impact factor: 4.849

9.  Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis.

Authors:  Christine B Ambrosone; Silke Kropp; Jun Yang; Song Yao; Peter G Shields; Jenny Chang-Claude
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-01-09       Impact factor: 4.254

10.  Hair dye use, meat intake, and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells.

Authors:  Christine B Ambrosone; Sara M Abrams; Katarzyna Gorlewska-Roberts; Fred F Kadlubar
Journal:  Arch Biochem Biophys       Date:  2007-06-08       Impact factor: 4.013

View more
  8 in total

1.  Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.

Authors:  Mark A Doll; Yu Zang; Timothy Moeller; David W Hein
Journal:  J Pharmacol Exp Ther       Date:  2010-04-29       Impact factor: 4.030

2.  Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline.

Authors:  Kristin J Metry; Jason R Neale; Jean Bendaly; Ned B Smith; William M Pierce; David W Hein
Journal:  Drug Metab Dispos       Date:  2009-08-10       Impact factor: 3.922

3.  Lack of association of the N-acetyltransferase NAT1*10 allele with prostate cancer incidence, grade, or stage among smokers in Finland.

Authors:  LaCreis R Kidd; David W Hein; Karen Woodson; Philip R Taylor; Demetrius Albanes; Jarmo Virtamo; Joseph A Tangrea
Journal:  Biochem Genet       Date:  2010-10-08       Impact factor: 1.890

4.  Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.

Authors:  David W Hein; Mark A Doll
Journal:  Pharmacogenomics       Date:  2011-11-17       Impact factor: 2.533

5.  Acetylator Genotype-Dependent Dyslipidemia in Rats Congenic for N-Acetyltransferase 2.

Authors:  Kyung U Hong; Mark A Doll; Angeliki Lykoudi; Raúl A Salazar-González; Mariam R Habil; Kennedy M Walls; Alaa F Bakr; Smita S Ghare; Shirish S Barve; Gavin E Arteel; David W Hein
Journal:  Toxicol Rep       Date:  2020-09-28

6.  Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver.

Authors:  Pengcheng Wang; Amina I Shehu; Jie Lu; Rujuta H Joshi; Raman Venkataramanan; Kim S Sugamori; Denis M Grant; Xiao-Bo Zhong; Xiaochao Ma
Journal:  Biochem Pharmacol       Date:  2017-09-06       Impact factor: 5.858

7.  Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism.

Authors:  Marcus W Stepp; Mark A Doll; David J Samuelson; Mary Ann G Sanders; J Christopher States; David W Hein
Journal:  BMC Cancer       Date:  2017-03-31       Impact factor: 4.430

8.  Folate-Dependent Hydrolysis of Acetyl-Coenzyme A by Recombinant Human and Rodent Arylamine N-Acetyltransferases.

Authors:  Marcus W Stepp; Galina Mamaliga; Mark A Doll; J Christopher States; David W Hein
Journal:  Biochem Biophys Rep       Date:  2015-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.